Literature DB >> 7912764

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation.

P Fontes1, A S Rao, A J Demetris, A Zeevi, M Trucco, P Carroll, W Rybka, W A Rudert, C Ricordi, F Dodson.   

Abstract

We have previously postulated that donor cell chimerism in organ transplantation is needed to attain a tolerant state. Here we show that donor cell chimerism can be augmented in organ recipients if they are infused perioperatively with 3 x 10(8) per kg of unmodified donor bone marrow cells and are kept on a conventional immunosuppressive regimen of tacrolimus (FK506) and prednisolone. 36 patients took part, of whom the first 18 patients have good transplanted kidney (n = 10), liver (n = 7), and heart (n = 7) function when followed up between 4 and 16 months. All patients are well. We found persistent multilineage leucocyte chimerism in blood of 17 recipients by flow cytometry and PCR techniques to detect donor alleles or Y chromosomes in female recipients of male organs. The use of the 5-antigben HLA matched same sex donor precluded detection of chimerism in one patient.

Entities:  

Mesh:

Year:  1994        PMID: 7912764      PMCID: PMC2962586          DOI: 10.1016/s0140-6736(94)92756-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

Review 1.  Cell migration, chimerism, and graft acceptance.

Authors:  T E Starzl; A J Demetris; N Murase; S Ildstad; C Ricordi; M Trucco
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

2.  Total lymphoid irradiation--current status.

Authors:  J A Myburgh; A M Meyers; P D Thomson; J R Botha; L Margolius; R Lakier; J A Smit; J H Stark; C Gray
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

Review 3.  Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.

Authors:  T E Starzl; K Abu-Elmagd; A Tzakis; J J Fung; K A Porter; S Todo
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

Review 4.  Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.

Authors:  T E Starzl; A J Demetris; M Trucco; N Murase; C Ricordi; S Ildstad; H Ramos; S Todo; A Tzakis; J J Fung
Journal:  Hepatology       Date:  1993-06       Impact factor: 17.425

5.  FK 506 for liver, kidney, and pancreas transplantation.

Authors:  T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

6.  Total lymphatic irradiation and bone marrow in human heart transplantation.

Authors:  D R Kahn; R Hong; A J Greenberg; E F Gilbert; G C Dacumos; J H Dufek
Journal:  Ann Thorac Surg       Date:  1984-08       Impact factor: 4.330

7.  Detection of Y chromosome sequences in Turner's syndrome by Southern blot analysis of amplified DNA.

Authors:  M Kocova; S F Siegel; S L Wenger; P A Lee; M Trucco
Journal:  Lancet       Date:  1993-07-17       Impact factor: 79.321

8.  Systemic chimerism in human female recipients of male livers.

Authors:  T E Starzl; A J Demetris; M Trucco; H Ramos; A Zeevi; W A Rudert; M Kocova; C Ricordi; S Ildstad; N Murase
Journal:  Lancet       Date:  1992-10-10       Impact factor: 79.321

9.  Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients.

Authors:  W H Barber; J A Mankin; D A Laskow; M H Deierhoi; B A Julian; J J Curtis; A G Diethelm
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

10.  Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation.

Authors:  T E Starzl; A J Demetris; M Trucco; A Zeevi; H Ramos; P Terasaki; W A Rudert; M Kocova; C Ricordi; S Ildstad
Journal:  Transplantation       Date:  1993-06       Impact factor: 4.939

View more
  94 in total

1.  The birth of clinical organ transplantation.

Authors:  T E Starzl
Journal:  J Am Coll Surg       Date:  2001-04       Impact factor: 6.113

2.  Donor bone marrow infusion in liver recipients: effect on the occurrence of acute cellular rejection.

Authors:  A S Rao; I Dvorchik; F Dodson; K Abu-Elmagd; A T Schaefer; L Ostrowski; M Valenti; A Zeevi; R Kuddus; T E Starzl; J J Fung
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

3.  Kidney transplantation with bone marrow augmentation: five-year outcomes.

Authors:  R Shapiro; A S Rao; R J Corry; M Valenti; A Zeevi; M L Jordan; V P Scantlebury; C A Vivas; A Jain; J McCauley; P Randhawa; E A Gray; I Dvorchik; J McMichael; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

4.  Hepatic and intestinal transplantation at the University of Pittsburgh.

Authors:  K Abu-Elmagd; J Fung; J Reyes; A Rao; A Jain; G Mazariegos; W Marsh; J Madariaga; I Dvorchik; J Bueno; J Rogers; J McMichael; F Dodson; H Vargus; J Martin; A Slivka; V Balan; R Corry; J Rakela; N Murase; J Demetris; S Iwatsuki; T Starzl
Journal:  Clin Transpl       Date:  1998

5.  Clinical intestinal transplantation in 1998: Pittsburgh experience.

Authors:  K M Abu-Elmagd; J Reyes; J J Fung; G Mazariegos; J Bueno; D Martin; J Colangelo; A Rao; A Demetris; T E Starzl
Journal:  Acta Gastroenterol Belg       Date:  1999 Apr-Jun       Impact factor: 1.316

6.  Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions.

Authors:  A S Rao; R Shapiro; R Corry; F Dodson; K Abu-Elmagd; S Pham; M Jordan; S Salgar; A Zeevi; C Rastellini; L Ostrowski; A Aitouche; R Keenan; J Reyes; B Griffith; T E Starzl; J J Fung
Journal:  Transplant Proc       Date:  1999 Feb-Mar       Impact factor: 1.066

7.  Evolution of clinical intestinal transplantation: improved outcome and cost effectiveness.

Authors:  K M Abu-Elmagd; J Reyes; J J Fung; G Mazariegos; J Bueno; C Janov; J Colangelo; A Rao; A Demetris; T E Starzl
Journal:  Transplant Proc       Date:  1999 Feb-Mar       Impact factor: 1.066

Review 8.  Tolerance induction for solid organ grafts with donor-derived hematopoietic reconstitution.

Authors:  K L Gandy
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

9.  The efficacy of daclizumab for intestinal transplantation: preliminary report.

Authors:  K Abu-Elmagd; J Fung; W McGhee; D Martin; G Mazariegos; N Schaefer; J Demetris; T E Starzl; J Reyes
Journal:  Transplant Proc       Date:  2000-09       Impact factor: 1.066

10.  In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Implications for the establishment and maintenance of donor cell chimerism following liver transplantation.

Authors:  A W Thomson; L Lu; V M Subbotin; Y Li; S Qian; A S Rao; J J Fung; T E Starzl
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.